Effect of eicosapentaenoic acid in asthma
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Summary: The role of arachidonic acid metabolites in the pathogenesis of airway inflammation and clinical asthma is currently unknown. The addition of eicosapentaenoic acid (EPA) to the diet of humans has been shown to generate metabolites that are less potent than their arachidonic acid counterparts. The substitution of EPA for arachidonic acid metabolites in patients might cause a decrease in airway inflammation and an improvement in clinical asthma. We studied the effect of addition of EPA to the diet of twelve asthmatic patients. Standard clinical evaluations and pulmonary function tests were done on weeks 0, 3, 6, 10, 12 and 14. Patients ingested either low‐dose EPA (0.1 g/day) or high‐dose EPA (4.0 g/day) from weeks 6–14 (total of 8 weeks). There was no difference in clinical status or pulmonary function between groups at the start of the study. There was no change in clinical status or pulmonary function between or within groups at the end of 8 weeks of EPA ingestion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lee, T. H., Hoover, R. L., Williams, J. D., Sperling, R. I., Ravalese, J., Spur, B. W., Robinson, D. R., Corey, E. J., Lewis, R. A., & Austen, K. F. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505093121903 · Cited by 1,333
Activation of basophil and mast cell histamine release by eosinophil granule major basic protein.
O'Donnell, M. C., Ackerman, S. J., Gleich, G. J., & Thomas, L. L. (1983) · The Journal of experimental medicine · doi:10.1084/jem.157.6.1981 · Cited by 321
Hyperalgesic properties of 15-lipoxygenase products of arachidonic acid
Levine, J. D., Lam, D., Taiwo, Y. O., Donatoni, P., & Goetzl, E. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.14.5331 · Cited by 129
Self-citation
Cited by
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
Calder, P. C. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1505s · Cited by 2,525
“Several studies have reported antiinflammatory effects of fish oil in patients with asthma, such as decreased 4-series LT production (162–164) and leukocyte chemotaxis (163, 164).”
BackgroundMarine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance
Calder, P. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.010 · Cited by 1,717
Omega‐3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?
Calder, P. C. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04374.x · Cited by 1,347
Dietary fat and asthma: is there a connection?
Black, P., & Sharpe, S. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10010006 · Cited by 491
Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease
Yates, C. M., Calder, P. C., & Ed Rainger, G. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.010 · Cited by 395
Metadata
- Authors
- KIRSCH, C. M., PAYAN, D. G., WONG, M. Y. S., DOHLMAN, J. G., BLAKE, V. A., PETRI, M. A., OFFENBERGER, J., GOETZL, E. J., & GOLD, W. M.
- Venue
- Clinical & Experimental Allergy
- Publisher
- Wiley
- Published
- 1988-03
- Volume
- 18
- Issue
- 2
- Pages
- 177-187
- ISSN
- 0954-7894 (ISSN-L)
- 1365-2222
- OpenAlex
- W2150630865
- Cited by
- 100
- References
- 3
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of eicosapentaenoic acid in asthma. https://app.cochat.ai/papers/10.1111/j.1365-2222.1988.tb02857.x
- The paper
- KIRSCH, C. M., PAYAN, D. G., WONG, M. Y. S., DOHLMAN, J. G., BLAKE, V. A., PETRI, M. A., OFFENBERGER, J., GOETZL, E. J., & GOLD, W. M. (1988). Effect of eicosapentaenoic acid in asthma. Clinical & Experimental Allergy. https://doi.org/10.1111/j.1365-2222.1988.tb02857.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.